Jim Simons
IPSC icon

Jim Simons’s Century Therapeutics IPSC Stock Holding History

Jim Simons’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.05M Sell
906,827
-442,373
-33% -$930K ﹤0.01% 1879
2025
Q4 		$1.34M Sell
1,349,200
-1,237,700
-48% -$755K ﹤0.01% 2107
2025
Q3 		$1.29M Buy
2,586,900
+564,400
+28% +$304K ﹤0.01% 2351
2025
Q2 		$1.13M Buy
2,022,500
+837,182
+71% +$449K ﹤0.01% 2450
2025
Q1 		$564K Sell
1,185,318
-17,567
-1% -$13.2K ﹤0.01% 2694
2024
Q4 		$1.21M Buy
1,202,885
+714,685
+146% +$973K ﹤0.01% 2380
2024
Q3 		$835K Buy
488,200
+322,700
+195% +$632K ﹤0.01% 2550
2024
Q2 		$422K Buy
165,500
+9,500
+6% +$30K ﹤0.01% 2774
2024
Q1 		$652K Buy
156,000
+36,800
+31% +$156K ﹤0.01% 2750
2023
Q4 		$396K Buy
119,200
+31,500
+36% +$57.4K ﹤0.01% 2875
2023
Q3 		$175K Buy
87,700
+20,400
+30% +$54.3K ﹤0.01% 3127
2023
Q2 		$213K Sell
67,300
-85,801
-56% -$277K ﹤0.01% 3278
2023
Q1 		$531K Buy
153,101
+48,001
+46% +$211K ﹤0.01% 2855
2022
Q4 		$539K Buy
+105,100
New +$992K ﹤0.01% 2917

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Jim Simons's IPSC Position: Q1 2026 in Review

Jim Simons reduced its Century Therapeutics (IPSC) stake by 33% in Q1 2026, selling an estimated $930K and leaving 906,827 shares worth $2.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1879.

Jim Simons first reported a position in IPSC in Q4 2022 and has held it in 14 quarters since. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

  • Jim Simons held 906,827 shares of Century Therapeutics worth $2.05M as of Q1 2026.
  • Jim Simons sold 442,373 Century Therapeutics shares in Q1 2026, an estimated $930K.
  • Century Therapeutics made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #1879 holding.
  • Jim Simons first reported a position in Century Therapeutics in Q4 2022 and has held it in 14 quarters since.
  • 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.